These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27163984)

  • 1. Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.
    Shaw P
    JAMA; 2016 May; 315(18):1953-5. PubMed ID: 27163984
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Storebø OJ; Simonsen E; Gluud C
    JAMA; 2016 May; 315(18):2009-10. PubMed ID: 27163989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?
    Gerlach M; Banaschewski T; Coghill D; Rohde LA; Romanos M
    Atten Defic Hyperact Disord; 2017 Mar; 9(1):1-3. PubMed ID: 28168407
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing?
    Mulder R; Hazell P; Rucklidge JJ; Malhi GS
    Aust N Z J Psychiatry; 2016 Feb; 50(2):113-4. PubMed ID: 26823533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 7. What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits.
    Carey WB
    Pediatrics; 2000 Apr; 105(4 Pt 1):863-4. PubMed ID: 10742336
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 10. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate for Comorbid Epilepsy and Attention-Deficit/Hyperactivity Disorder.
    Naguy A; Alrashidi F; Elsori D
    Am J Ther; 2019; 26(6):e718-e720. PubMed ID: 31567149
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible effect of methylphenidate on secondary encopresis in children with attention-deficit/hyperactivity disorder.
    Bilgiç A
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):647. PubMed ID: 21130131
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report.
    Schweickert LA; Strober M; Moskowitz A
    Int J Eat Disord; 1997 Apr; 21(3):299-301. PubMed ID: 9097204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Hergüner S; Tanidir C
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
    [No Abstract]   [Full Text] [Related]  

  • 17. Can methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?
    Jerome L
    J Child Adolesc Psychopharmacol; 2001; 11(1):109. PubMed ID: 11322740
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.
    Bonati M; Impicciatore P; Pandolfini C
    BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of methylphenidate in the treatment of encopresis whether or not attention-deficit/hyperactivity disorder symptoms are present.
    Yilmaz S; Akça OF
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):632-3. PubMed ID: 24251646
    [No Abstract]   [Full Text] [Related]  

  • 20. Attention-deficit-hyperactivity disorder.
    Diller LH
    N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.